At Ami Lifesciences Pvt. Limited, I founded a CDMO business line and onboarded five accounts across the USA, EU, and Japan. I also secured a 10+ year exclusive supply agreement with a Japanese innovator for pharmaceutical intermediates.
At Jubilant Ingrevia Ltd., I managed full-cycle sales for a $9M pipeline and founded a Semiconductor Chemicals Division, growing it from zero to $0.75M in global sales. I launched more than 10 semiconductor chemical products and partnered with R&D, QA, and Production to reduce tech-transfer issues.
At Viatris (Mylan Laboratories), I negotiated a three-year, $12M supply agreement for injectables and biosimilars and helped drive EU market entry for two biosimilar products. Earlier, at Teva Pharmaceuticals and Solara Active Pharmaceutical Ltd., I worked across API strategy and CDMO programs, including managing more than 10 programs end-to-end.

